SABRA MAZIN 4

What Happened

• Sabra Mazin, Chief Operating Officer of ClearPoint Neuro (CLPT), had 26,101 restricted stock units (RSUs) settle into common shares on 2026-03-12. To satisfy tax withholding obligations, 13,281 of those shares were delivered back to the company at $11.53 per share for a total withholding of $153,130. Net newly issued shares retained by Mazin from this vesting: 12,820.

Key Details

• Transaction date: 2026-03-12; Form 4 filed 2026-03-16 (timely within required reporting window).
• Primary transaction codes: M = exercise/conversion of derivative (RSU settlement), F = shares delivered to satisfy tax withholding.
• Shares acquired on vesting: 26,101 RSUs converted to common stock (price N/A for settlement).
• Shares withheld for taxes: 13,281 shares at $11.53 each = $153,130.
• Net shares retained from this vesting: 12,820.
• Footnotes: F1 confirms each RSU converts to one CLPT common share on vesting; F2 confirms the 13,281 shares were surrendered to satisfy withholding.

Context

• This was an RSU vesting event (an award being settled), not an open-market buy or sale for investment purposes. The withholding of shares to cover taxes is routine and does not necessarily indicate a view on the company's stock.